The Effect of Adherence-Enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): a Quasi-Experimental Pre-Post Intervention Multicenter Pilot Study
ConclusionTyrosine kinase inhibitor adherence is improved by this pilot intervention, mainly in patients with suboptimal baseline adherence.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Health Management | Hematology | Israel Health | Leukemia | Lymphoma | Middle East Health | Myeloma | Study | Training | Universities & Medical Training